Changes in mouse brain serotonin turnover following chronic imipramine administration

Area of Science:

• Neuropharmacology
• Biochemistry

Background:

• Serotonin (5-HT) is a key neurotransmitter involved in mood regulation.
• Tricyclic antidepressants (TCAs) like imipramine are commonly used to treat depression.
• Understanding the precise mechanisms of TCA action on serotonin pathways is crucial.

Purpose of the Study:

• To investigate the effects of imipramine on serotonin turnover in various brain regions of mice.
• To determine how imipramine interacts with agents that modulate serotonin synthesis and metabolism.

Main Methods:

• Mice were treated with saline, tryptophan, p-chlorophenylalanine (PCPA), or imipramine.
• Serotonin turnover was assessed by measuring serotonin accumulation after pargyline and 5-hydroxyindoleacetic acid (5-HIAA) levels after probenecid.
• Regional brain analysis included hypothalamus and cerebellum.

Main Results:

• Imipramine alone generally decreased serotonin turnover, with a more pronounced effect in the hypothalamus than the cerebellum.
• Chronic imipramine treatment completely inhibited the tryptophan-induced increase in serotonin turnover.
• Imipramine did not alter the reduced serotonin turnover caused by PCPA.

Conclusions:

• Imipramine exhibits a dose-dependent effect on serotonin turnover, with regional variations in the brain.
• The drug's ability to block serotonin synthesis enhancement suggests a complex interaction with serotonergic systems.
• These findings provide insights into the neurochemical basis of antidepressant action.